Table 2.
Inflammatory mediators | Timepoints | Control Group (n = 33) | Dex Group (n = 33) | p value |
---|---|---|---|---|
LPS, EU/ml | T0 | 135.1 (79.6) | 125.5 (85.2) | 0.638 |
T1 | 120.8 (77.4) | 94.8 (58.6)* | 0.366 | |
T2 | 103.5 (61.1)* | 90.5 (55.6)* | 0.509 | |
T3 | 100.1 (61.4)* | 80.5 (39.8)* | 0.133 | |
T4 | 99.2 (53.8)* | 75.3 (41.9)* | 0.076 | |
TNF-α, pg/ml | T0 | 15.13 (10.56) | 16.37 (12.71) | 0.944 |
T1 | 15.18 (10.14) | 16.35 (12.52) | 0.928 | |
T2 | 62.68 (39.56)* | 59.55 (30.33)* | 0.969 | |
T3 | 74.89 (39.80)* | 72.81 (40.53)* | 0.663 | |
T4 | 64.71 (37.50)* | 61.26 (37.22)* | 0.847 | |
CRP, ng/ml | T0 | 454.2 (344.3) | 465.8 (407.0) | 0.901 |
T1 | 386.9 (308.1) | 403.7 (359.4) | 0.686 | |
T2 | 13702 (2090)* | 12972 (2030)* | 0.155 | |
T3 | 14298 (2099)* | 13543 (2334)* | 0.162 | |
T4 | 13706 (3111)* | 12576 (3263)* | 0.079 |
Data were expressed as mean (SD). *compared with T0, P < 0.05; P in the table indicated the significant differences between two groups.
Dex, dexmedetomidine; LPS, lipopolysaccharides; TNF-α, tumor necrosis factor-α; CRP, C-reactive protein; T0, baseline before induction; T1, at the end of surgery; T2, 24 h after surgery; T3, 48 h after surgery; T4, 72 h after surgery.